1
|
Worley A and Grimmer-Somers K: Risk
factors for glaucoma: what do they really mean? Aust J Prim Health.
17:233–239. 2011. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Wong VH, Bui BV and Vingrys AJ: Clinical
and experimental links between diabetes and glaucoma. Clin Exp
Optom. 94:4–23. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Yanagi M, Kawasaki R, Wang JJ, Wong TY,
Crowston J and Kiuchi Y: Vascular risk factors in glaucoma: a
review. Clin Experiment Ophthalmol. 39:252–258. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hayreh SS: Neovascular glaucoma. Prog
Retin Eye Res. 26:470–485. 2007. View Article : Google Scholar
|
5
|
Chan HC, Chang RC, Koon-Ching Ip A, et al:
Neuroprotective effects of Lycium barbarum Lynn on
protecting retinal ganglion cells in an ocular hypertension model
of glaucoma. Exp Neurol. 203:269–273. 2007.
|
6
|
Mi XS, Zhong JX, Chang RC and So KF:
Research advances on the usage of traditional Chinese medicine for
neuroprotection in glaucoma. J Integr Med. 11:233–240. 2013.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Cheng TO: Cardiovascular effects of
Danshen. Int J Cardiol. 121:9–22. 2007. View Article : Google Scholar
|
8
|
Qin RA, Yao XX and Huang ZY: Effects of
compound danshen tablets on spatial cognition and expression of
brain beta-amyloid precursor protein in a rat model of Alzheimer’s
disease. J Tradit Chin Med. 32:63–66. 2012.PubMed/NCBI
|
9
|
Jensen RJ and Rizzo JF III: Responses of
ganglion cells to repetitive electrical stimulation of the retina.
J Neural Eng. 4:S1–S6. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ko ML, Hu DN, Ritch R and Sharma SC: The
combined effect of brain-derived neurotrophic factor and a free
radical scavenger in experimental glaucoma. Invest Ophthalmol Vis
Sci. 41:2967–2971. 2000.PubMed/NCBI
|
11
|
Wilensky JT, Gieser DK, Mori MT,
Langenberg PW and Zeimer RC: Self-tonometry to manage patients with
glaucoma and apparently controlled intraocular pressure. Arch
Ophthalmol. 105:1072–1075. 1987. View Article : Google Scholar : PubMed/NCBI
|
12
|
Rhee DJ1, Katz LJ, Spaeth GL and Myers JS:
Complementary and alternative medicine for glaucoma. Surv
Ophthalmol. 46:43–55. 2001. View Article : Google Scholar : PubMed/NCBI
|
13
|
Huynh TP1, Mann SN and Mandal NA:
Botanical compounds: effects on major eye diseases. Evid Based
Complement Alternat Med. 2013:5491742013.PubMed/NCBI
|
14
|
Yue KK, Lee KW, Chan KK, Leung KS, Leung
AW and Cheng CH: Danshen prevents the occurrence of oxidative
stress in the eye and aorta of diabetic rats without affecting the
hyperglycemic state. J Ethnopharmacol. 106:136–141. 2006.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Liu Q, Zhang Y, Lin Z, et al: Danshen
extract 15,16-dihydrotanshinone I functions as a potential
modulator against metabolic syndrome through multi-target pathways.
J Steroid Biochem Mol Biol. 120:155–163. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Qi HP, Wei SQ, Zhang LQ, et al: Preventive
effect of danshensu on selenite-induced cataractogenesis in
cultured rat lens. Clin Experiment Ophthalmol. 41:172–179. 2013.
View Article : Google Scholar : PubMed/NCBI
|